Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ:001540)
South Korea
· Delayed Price · Currency is KRW 6,340.00
-250.00 (-3.79%)
At close: Mar 31, 2025, 3:30 PM KST
Ahn-Gook Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 16,845 | 1,290 | 6,875 | 3,939 | -1,315 | Upgrade
|
| Depreciation & Amortization | 7,698 | 5,023 | 4,930 | 4,507 | 4,683 | Upgrade
|
| Loss (Gain) From Sale of Assets | -13,216 | -17.13 | -28.25 | -138.65 | 60.42 | Upgrade
|
| Asset Writedown & Restructuring Costs | 219.98 | - | 37.78 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -229.34 | -920.69 | 889.36 | -2,033 | -625.7 | Upgrade
|
| Loss (Gain) on Equity Investments | -1,352 | 1,641 | 1,645 | -2,613 | -1,780 | Upgrade
|
| Provision & Write-off of Bad Debts | -83.27 | 757.97 | 129.7 | 171.68 | 1,025 | Upgrade
|
| Other Operating Activities | 8,165 | 4,747 | 5,478 | 8,724 | 5,462 | Upgrade
|
| Change in Accounts Receivable | 3,541 | -7,972 | -11,980 | -10,171 | 8,940 | Upgrade
|
| Change in Inventory | -10,008 | -12,861 | -4,497 | -3,969 | -1,260 | Upgrade
|
| Change in Accounts Payable | -4,931 | 2,569 | 2,528 | 1,090 | -1,506 | Upgrade
|
| Change in Other Net Operating Assets | -1,735 | 4,415 | -4,219 | 1,964 | -2,493 | Upgrade
|
| Operating Cash Flow | 4,914 | -1,328 | 1,788 | 1,472 | 11,190 | Upgrade
|
| Operating Cash Flow Growth | - | - | 21.49% | -86.84% | -49.32% | Upgrade
|
| Capital Expenditures | -75,887 | -5,474 | -2,931 | -4,035 | -24,119 | Upgrade
|
| Sale of Property, Plant & Equipment | 11,833 | 11,201 | 15.5 | 42.09 | 26.98 | Upgrade
|
| Sale (Purchase) of Intangibles | -395.05 | -708.77 | -735.39 | -1,028 | -354.78 | Upgrade
|
| Investment in Securities | -10,938 | 12,167 | 9,960 | 4,931 | 15,021 | Upgrade
|
| Other Investing Activities | 0 | 0 | -0 | 62.75 | - | Upgrade
|
| Investing Cash Flow | -75,386 | 17,186 | 6,431 | 3,118 | -9,426 | Upgrade
|
| Long-Term Debt Issued | 60,000 | 10,000 | - | - | 2,500 | Upgrade
|
| Long-Term Debt Repaid | -301.93 | -12,593 | -662.99 | -889.69 | -11,439 | Upgrade
|
| Net Debt Issued (Repaid) | 59,698 | -2,593 | -662.99 | -889.69 | -8,939 | Upgrade
|
| Repurchase of Common Stock | - | - | -554 | -435.14 | - | Upgrade
|
| Dividends Paid | -2,500 | -2,500 | -2,511 | -2,521 | -2,521 | Upgrade
|
| Other Financing Activities | -0 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 57,198 | -5,093 | -3,728 | -3,846 | -11,460 | Upgrade
|
| Foreign Exchange Rate Adjustments | 127.64 | 8.08 | 77.69 | 136.61 | -281.98 | Upgrade
|
| Net Cash Flow | -13,147 | 10,772 | 4,569 | 881.42 | -9,978 | Upgrade
|
| Free Cash Flow | -70,972 | -6,802 | -1,143 | -2,563 | -12,929 | Upgrade
|
| Free Cash Flow Margin | -26.18% | -2.91% | -0.56% | -1.57% | -9.02% | Upgrade
|
| Free Cash Flow Per Share | -6243.89 | -601.03 | -100.42 | -223.77 | -1022.23 | Upgrade
|
| Cash Interest Paid | 2,665 | 976.99 | 662.47 | 121.11 | 414.62 | Upgrade
|
| Cash Income Tax Paid | 652.73 | 2,921 | 713.85 | 101.29 | 3,301 | Upgrade
|
| Levered Free Cash Flow | -82,472 | 4,491 | 1,732 | -988.07 | -12,257 | Upgrade
|
| Unlevered Free Cash Flow | -80,595 | 4,581 | 1,832 | -915.05 | -11,784 | Upgrade
|
| Change in Net Working Capital | 16,185 | -2,577 | 5,295 | -317.8 | -8,037 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.